| The tumour-promoting receptor tyrosine kinase, EphB4, regulates expression of Integrin-β8 in prostate cancer cells I Mertens-Walker, BC Fernandini, MSN Maharaj, A Rockstroh, CC Nelson, ... BMC cancer 15, 1-10, 2015 | 109 | 2015 |
| Phenotypic characterization of prostate cancer LNCaP cells cultured within a bioengineered microenvironment S Sieh, AV Taubenberger, SC Rizzi, M Sadowski, ML Lehman, ... Public Library of Science 7 (9), e40217, 2012 | 105 | 2012 |
| A molecular portrait of epithelial–mesenchymal plasticity in prostate cancer associated with clinical outcome N Stylianou, ML Lehman, C Wang, AT Fard, A Rockstroh, L Fazli, ... Oncogene 38 (7), 913-934, 2019 | 89 | 2019 |
| Therapy-induced lipid uptake and remodeling underpin ferroptosis hypersensitivity in prostate cancer KD Tousignant, A Rockstroh, BLJ Poad, A Talebi, RSE Young, ... Cancer & metabolism 8, 1-21, 2020 | 73 | 2020 |
| Lipid uptake is an androgen-enhanced lipid supply pathway associated with prostate cancer disease progression and bone metastasis KD Tousignant, A Rockstroh, A Taherian Fard, ML Lehman, C Wang, ... Molecular Cancer Research 17 (5), 1166-1179, 2019 | 65 | 2019 |
| A 3D tumor microenvironment regulates cell proliferation, peritoneal growth and expression patterns D Loessner, A Rockstroh, A Shokoohmand, BM Holzapfel, F Wagner, ... Biomaterials 190, 63-75, 2019 | 55 | 2019 |
| Gene expression based inference of cancer drug sensitivity S Chawla, A Rockstroh, M Lehman, E Ratther, A Jain, A Anand, A Gupta, ... Nature communications 13 (1), 5680, 2022 | 49 | 2022 |
| Kallikrein-related peptidases 4, 5, 6 and 7 regulate tumour-associated factors in serous ovarian cancer P Wang, V Magdolen, C Seidl, J Dorn, E Drecoll, M Kotzsch, F Yang, ... British journal of cancer 119 (7), 1-9, 2018 | 34 | 2018 |
| 6α-Acetoxyanopterine: A novel structure class of mitotic inhibitor disrupting microtubule dynamics in prostate cancer cells C Levrier, MC Sadowski, A Rockstroh, B Gabrielli, M Kavallaris, ... Molecular cancer therapeutics 16 (1), 3-15, 2017 | 25 | 2017 |
| Identification of a novel fusion transcript between human relaxin-1 (RLN1) and human relaxin-2 (RLN2) in prostate cancer G Tevz, S McGrath, R Demeter, V Magrini, V Jeet, A Rockstroh, ... Molecular and Cellular Endocrinology 420, 159-168, 2016 | 24 | 2016 |
| The ascidian natural product eusynstyelamide B is a novel topoisomerase II poison that induces DNA damage and growth arrest in prostate and breast cancer cells MS Liberio, MC Sadowski, RA Davis, A Rockstroh, R Vasireddy, ... Oncotarget 6 (41), 43944, 2015 | 24 | 2015 |
| The human topoisomerase I damage response plays a role in apoptosis K Søe, A Rockstroh, P Schache, F Grosse DNA repair 3 (4), 387-393, 2004 | 24 | 2004 |
| Adiponectin receptor activation inhibits prostate cancer xenograft growth LK Philp, A Rockstroh, M Lehman, MC Sadowski, N Bartonicek, JD Wade, ... Endocrine-Related Cancer 27 (12), 711-729, 2020 | 17 | 2020 |
| The molecular function of kallikrein‐related peptidase 14 demonstrates a key modulatory role in advanced prostate cancer T Kryza, N Bock, S Lovell, A Rockstroh, ML Lehman, A Lesner, ... Molecular oncology 14 (1), 105-128, 2020 | 17 | 2020 |
| Discovery of thalicthuberine as a novel antimitotic agent from nature that disrupts microtubule dynamics and induces apoptosis in prostate cancer cells C Levrier, A Rockstroh, B Gabrielli, M Kavallaris, M Lehman, RA Davis, ... Cell Cycle 17 (5), 652-668, 2018 | 16 | 2018 |
| Extracellular vesicles in the adaptive process of prostate cancer during inhibition of androgen receptor signaling by enzalutamide C Soekmadji, A Rockstroh, GA Ramm, CC Nelson, PJ Russell Proteomics 17 (23-24), 1600427, 2017 | 16 | 2017 |
| Enhancement of biological effectiveness of radiotherapy treatments of prostate cancer cells in vitro using gold nanoparticles L Sim, A Fielding, M English, E Waclawik, A Rockstroh, C Soekmadji, ... International Nanomedicine Conferene, 1-2, 2011 | 16 | 2011 |
| Neuropilin-1 is over-expressed in claudin-low breast cancer and promotes tumor progression through acquisition of stem cell characteristics and RAS/MAPK pathway activation YH Tang, A Rockstroh, KA Sokolowski, LR Lynam, M Lehman, ... Breast Cancer Research 24 (1), 8, 2022 | 13 | 2022 |
| Cellular stress triggers the human topoisomerase I damage response independently of DNA damage in a p53 controlled manner A Rockstroh, A Kleinert, M Kramer, F Grosse, K Søe Oncogene 26 (1), 123-131, 2007 | 11 | 2007 |
| Leptin antagonism inhibits prostate cancer xenograft growth and progression LK Philp, A Rockstroh, MC Sadowski, AT Fard, M Lehman, G Tevz, ... Endocrine-related cancer 28 (5), 353-375, 2021 | 10 | 2021 |
